Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL465558 | 0.98 | TSHR (0.67) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL7193941 | 0.96 | TSHR (0.63) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL4805738 | 0.93 | TSHR (0.64) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL7194633 | 0.88 | TSHR (0.56) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL13974192 | 0.83 | TSHR (1.00) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL17549553 | 0.83 | TSHR (1.00) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL17549552 | 0.83 | TSHR (1.00) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL17549551 | 0.83 | TSHR (1.00) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL21272 | 0.83 | TSHR (1.00) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 | |
| SCHEMBL3843910 | 0.81 | TSHR (0.64) | TSHRALDH1A1TDP1SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1214382-A1 | PIGMENTED COATINGS FOR CERAMIC SUBSTRATES | PPG Industries Ohio, Inc. (US) | 2002-06-19 | — | — | EP | claimed |
| US-6214414-B1 | HEATING TO CERAMIC SUBSTRATE HAVING SEQUENCE OF COATINGS OF PIGMENTED COATING TO CROSSLINK ALL OF PIGMENTED COATING OF SEQUENCE AND TO ADHERE SEQUENCE TO THE CERAMIC SUBSTRATE | PPG INDUSTRIES OHIO, INC. | 2001-04-10 | — | — | US | claimed |
| WO-2001007528-A1 | PIGMENTED COATINGS FOR CERAMIC SUBSTRATES | PPG INDUSTRIES OHIO, INC. (US) | 2001-02-01 | — | — | WO | claimed |
| WO-2001007376-A1 | METHOD FOR FORMING A SEQUENCE OF CROSSLINKED PIGMENTED COATINGS ON CERAMIC SUBSTRATES | PPG INDUSTRIES OHIO, INC. (US) | 2001-02-01 | — | — | WO | claimed |
| US-5674941-A | CURABLE PROTECTIVE COATING FOR OPTICAL ARTICLES COMPRISING AN AMINE-CONTAINING SILANE AND AN ACRYLIC COPOLYMER HAVING PENDANT HYDROXY, EPOXY, AMINO AND/OR SILANE GROUPS; ANTIFOGGING AGENTS; ADHESION TO POLYCARBONATES; NONABRASIVE | LUCKY LIMITED (KR) | 1997-10-07 | — | — | US | claimed |
| US-20240158904-A1 | UNDERCOAT AGENT COMPOSITION FOR LAYERING INORGANIC MATERIAL LAYER, CURED PRODUCT THEREOF AND PRODUCTION METHOD THEREOF | TOAGOSEI CO., LTD. (JP) | 2024-05-16 | — | — | US | disclosed |
| EP-4289618-A1 | UNDERCOAT AGENT COMPOSITION FOR INORGANIC SUBSTANCE LAYER LAMINATION, CURED PRODUCT THEREOF, AND METHOD FOR PRODUCING SAME | Toagosei Co., Ltd. (JP) | 2023-12-13 | — | — | EP | disclosed |
| EP-4269516-A1 | COMPOSITION FOR HYBRID POLYMERS HAVING BARRIER FUNCTION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-11-01 | — | — | EP | disclosed |
| WO-2023171514-A1 | LAMINATE AND PACKAGING MATERIAL | DIC株式会社 | 2023-09-14 | — | — | WO | disclosed |
| US-11738091-B2 | Method for terminating cancer cells with an azole-based compound | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-08-29 | — | — | US | disclosed |
| US-20230087061-A1 | METHOD FOR TERMINATING CANCER CELLS WITH AN AZOLE-BASED COMPOUND | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-03-23 | — | — | US | disclosed |
| US-11564994-B2 | Method for making a conjugate azole-based surface modified silicon dioxide nanoparticle | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2023-01-31 | — | — | US | disclosed |
| US-6039896-A | RESINS, ORGANIC PEROXIDE, THERMOPLASTIC ELASTOMERS AND PHOSPHORIC ESTERS | SUMITOMO BAKELITE CO., LTD. (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5877232-A | WEAR RESISTANCE; DIMENSIONAL STABILITY; SHRINKAGE INHIBITION | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-02 | — | — | US | disclosed |
| US-5756767-A | Hydrolyzable and polyhmerizable silanes | WOLTER HERBERT (DE) | 1998-05-26 | — | — | US | disclosed |
| US-5674941-A | CURABLE PROTECTIVE COATING FOR OPTICAL ARTICLES COMPRISING AN AMINE-CONTAINING SILANE AND AN ACRYLIC COPOLYMER HAVING PENDANT HYDROXY, EPOXY, AMINO AND/OR SILANE GROUPS; ANTIFOGGING AGENTS; ADHESION TO POLYCARBONATES; NONABRASIVE | LUCKY LIMITED (KR) | 1997-10-07 | — | — | US | disclosed |
| EP-0643752-A1 | RESINOUS DENTAL COMPOSITION BASED ON POLYMERISABLE POLYSILOXANES | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-22 | — | — | EP | disclosed |
| EP-0643752-A4 | RESINOUS DENTAL COMPOSITION BASED ON POLYMERISABLE POLYSILOXANES. | PROCTER & GAMBLE (US) | 1994-06-03 | — | — | EP | disclosed |
| WO-1993007230-A1 | RESINOUS DENTAL COMPOSITION BASED ON POLYMERISABLE POLYSILOXANES | THE PROCTER & GAMBLE COMPANY (US) | 1993-04-15 | — | — | WO | disclosed |
| US-4642266-A | SCRATCH RESISTANCE AND WEATHERABILITY | NIPPON SHEET GLASS CO., LTD. (JP) | 1987-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11564994-B2 | Method for making a conjugate azole-based surface modified silicon dioxide nanoparticle | APC, AS3MT, SI | TSHR 189/4885ALDH1A1 2798/4885TDP1 3373/4885 |
| US-11738091-B2 | Method for terminating cancer cells with an azole-based compound | APC, CCNI, TTI1 | TSHR 307/4885ALDH1A1 2408/4885TDP1 2794/4885 |
| US-20230087061-A1 | METHOD FOR TERMINATING CANCER CELLS WITH AN AZOLE-BASED COMPOUND | APC, CCNI, TTI1 | TSHR 307/4885ALDH1A1 2408/4885TDP1 2794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.